Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.910196
Abstract: Introduction CD105 is an angiogenic biomarker that is useful to determine the microvessel density (MVD) within a tumor, namely, in highly vascularized tumors like glioblastoma (GBM). However, its expression has shown inconsistent associations with the… read more here.
Keywords: cd105; expression; mvd cd105; gbm patients ... See more keywords